Healthcare -
Biotechnology - NASDAQ - US
$ 1.205
2.12 %
$ 94.7 M
Market Cap
-1.8
P/E
SLS - TOTAL CURRENT LIABILITIES
Total Current Liabilities SLS - SELLAS Life Sciences Group, Inc.
13.7 M
LAST VALUE
66.04%
2 YEAR CAGR
18.12%
5 YEAR CAGR
-14.05%
10 YEAR CAGR